Clinical trial for effectiveness and safety of percutaneous transhepatic gallbladder aspiration in patients with acute cholecystitis

Clinical trial for effectiveness and safety of percutaneous transhepatic gallbladder aspiration in patients with acute cholecystitis - PTGBA for acute cholecystitis

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000002052

Enrollment

Registered

2009-06-10

Start date

2007-12-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acute cholecystitis

Interventions

percutaneous transhepatic gallbladder aspiration conservative therapy

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients with mild acute cholecystitis, which is defined by "Tokyo Guidelines for the management of acute cholangitis and cholecystitis"

Exclusion criteria

Exclusion criteria: 1) Patients with choledocholithiasis 2) Patients with acalculous cholecystitis 3) Patients with moderate or severe cholecystitis 4) Patients whom symptoms are improving 5) Patients with serious complications 6) Patients with other infectious disease 7) Patients with suspected gallbladder cancer 8) Patients with the bleeding tendency 9) Patients receiving anticoagulants 10) Patients with previous history of antibiotic hypersensitivity 11) Patients with the pregnancy or the pregnant likelihood 12) Inappropriate patients for entry on this study by the judgment of the investigators

Design outcomes

Primary

Measure	Time frame
Improvement of right hypochondralgia at the 24-hour and/or 72-hour treatment	—

Secondary

Measure	Time frame
treatment period safety	—

Countries

Japan

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026